Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 2004;94:e85

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Brophy, C. M.
Right arrow Articles by Komalavilas, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Brophy, C. M.
Right arrow Articles by Komalavilas, P.
(Circulation Research. 2004;94:e85.)
© 2004 American Heart Association, Inc.


Letters to the Editor

Heat Shock–Related Protein 20 (HSP20) in Cardiomyocytes

Colleen M. Brophy, Padmini Komalavilas

Harrington Department of Bioengineering and Arizona, Biodesign Institute, Arizona State University, Tempe, Ariz, and, Carl T. Hayden Veteran’s Affairs Medical Center, Phoenix, Ariz, colleen.brophy@asu.edu


An extract of the first 250 words of the full text is provided, because this article has no abstract.
 

To the Editor:

In the article, "Phosphoproteome analysis of cardiomyocytes subjected to ß-adrenergic stimulation," Chu et al concluded that "a de novo phosphorylation of a cardiac heat shock protein p20 was identified, for the first time, in mouse cardiomyocytes, after prolonged activation of the ß-adrenergic signaling pathway.1 However, cyclic nucleotide-dependent phosphorylation of p20, also referred to as heat shock-related protein 20 (HSP20), has been well characterized in smooth, skeletal, and cardiac muscles.2 The phosphorylation on serine 16 has also been described.3 Thus, the novelty of this report by Chu et al is limited to the animal model (mouse) and the modality of stimulation (ß-adrenergic).

Chu et al used adenoviral transfection of p20 to determine the functional relevance of the protein. They suggested that transfection of p20 leads to "increased cell contractility and intracellular calcium transients amplitudes." Our group used a different approach, that of transiently permeabililzing rat cardiomyocytes and treating the cells with phosphopeptide analogues of p20 to elucidate the function of this molecule.2 The phosphopeptide analogue, but not scrambled peptide controls, led to an increased rate of contractility because of a more rapid relaxation time. We found no change in the amplitude of the calcium transient; however, there was a more rapid rate of decay of the calcium transient. Chu et al did not indicate what the transfection efficiency was, nor did they provide any information on changes in p20 expression or phosphorylation after transfection. Without this information, it is difficult to compare and contrast the differing results.

. . . [Full Text of this Article]